Skip to content

News archive

  • NNIT reports challenging start to 2026

    NNIT’s first quarter financial results reflect a challenging start to the year marked by continued geopolitical turmoil and sustained customer caution, particularly within the life sciences IT consulting industry. Revenue declined compared to the same period last year, and order entry was below plan.

    NNIT reports challenging start to 2026
  • Claus Rydkjær joins NNIT as Chief Executive Officer

    Claus Rydkjær joins NNIT as Chief Executive Officer. He steps into the role as the company continues executing its strategy with a strong focus on expanding its global life sciences business and strengthening its position within the Danish public sector.

    Claus Rydkjær joins NNIT as Chief Executive Officer.
  • NNIT accelerates its industry focus

    NNIT accelerates its industry focus: With more than 30 years of experience delivering IT consultancy and digital solutions to the life science industry and the public sector, NNIT is now taking further steps in its strategic industry focus.

    NNIT Accelerates Its Industry Focus
  • NNIT strengthens profitability in Q3 2025 through continued operational efficiency and solid order momentum

    NNIT delivered another step‑up in profitability in the third quarter of 2025 while maintaining revenue in line with expectations despite a globally uncertain environment. Improved utilization, cost discipline, and positive order trends supported stronger margins across the business.
    NNIT continued the positive momentum from late Q2 2025, driven by an uplift in customer activity and solid order

  • NNIT improves profitability in Q2 2025 despite declining revenue and continued market uncertainty

    In the second quarter of 2025, NNIT delivered stronger profitability than in the first quarter, even as revenue declined year‑on‑year, driven by the impact of cost‑reduction initiatives, improved project execution, and a sharper focus on repeatable solutions.
    Market conditions across regions, especially in Europe, remained challenging with life sciences customers still cautious in committing to

  • Eirgen and NNIT collaborate on digital manufacturing transformation

    NNIT is pleased to announce its role as a strategic implementation partner for Eirgen Pharma’s new Electronic Batch Record (EBR) system, internally referred to as Project Elevate. This initiative is a cornerstone of Eirgen’s digital transformation strategy and marks a decisive shift away from manual, paper-based batch documentation toward a fully digitized, real-time operational environment. The s

  • NNIT releases financial results for Q1 2025

    The overall financial performance in Q1 2025 shows flat growth due to a challenging start to the year.
    NNIT’s Q1 2025 financial performance was expected to be moderate, but the increased macroeconomic and geopolitical uncertainty has impacted the company to a larger extent than expected. First quarter showed a flat growth and based on the realized results and the continued uncertainty, NNIT ad

Show more